AL002

· Alector Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AL002, covering 2025-10-29 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease [Phase 2]

See pricing